Sierra Rutile Holdings Limited

For FY2025, total revenue grew 4.5%, with hospitals up 4.3% and Primary Care revenue up 7.4% to GBP 133.7 million. Adjusted EBITDA rose 3.2% to GBP 268.6 million; Hospital Business adjusted EBITDA increased 3.9% to GBP 258.8 million, with a 17.9% margin, and adjusted profit before tax was GBP 46.5 million, down 7.4%. Adjusted free cash flow increased 64.9% to GBP 64.3 million, CapEx fell 30% to GBP 78.5 million, statutory profit after tax was GBP 17.2 million, and ROCE was 8% versus 8.2% in 2024. Looking ahead, management expects private patient growth of mid- to high-single-digit percent in 2026, NHS revenue down about 25% in Q1 2026, NHS revenue down 5% to 10% in Q2-Q4 under the base scenario, and 2026 adjusted EBITDA broadly in line with 2025.

Justin Ash framed 2025 as a year of resilient execution despite labor inflation and a tougher NHS commissioning backdrop, emphasizing that Spire leaned on its strategy: private-pay growth, transformation, primary care expansion, and quality. He highlighted tangible operating improvements such as better brand awareness, 95% call answer rates at patient support centers, AI-driven pricing and MRI throughput gains, and 29 surgical robots across the estate. His tone was constructive but cautious: he repeatedly called 2026 a transitionary period because NHS volumes are uncertain, while expressing confidence in self-pay momentum, commissioning relationships, and the company’s medium-term private-market opportunity.

Harbant Samra said FY2025 revenue rose 4.5%, adjusted EBITDA reached GBP 268.6 million, and adjusted free cash flow climbed to GBP 64.3 million, while CapEx declined to GBP 78.5 million, or 5% of revenue versus 6% to 7% historically. He said the GBP 30 million transformation savings offset around two-thirds of cost inflation, including higher National Insurance and National Minimum Wage costs, and that Hospital EBITDA margin held at 17.9%. He also noted leverage remained at 2x after the Acorn and Physiolistic acquisitions, bank facility maturity was extended to August 2028, and the 2026 savings plan is being accelerated with more than GBP 30 million of savings targeted to at least offset the Q1 NHS shortfall.

Analysts pressed on PMI pricing, NHS volume phasing, self-pay competition, energy hedging, and the strategic review. Management said PMI discussions remain constructive and increasingly cover broader offerings such as primary care, while NHS volumes are expected to be lumpy as commissioners balance financial discipline with waiting-list pressure. On self-pay, management argued Spire is better positioned because it has improved phone response, same-day booking, consultant diary access, MRI capacity, and digital marketing; on energy, it said costs are fixed through Q1 2027; and on the strategic review, it reiterated that options remain open but no certainty exists on any offer.